Runt-Related Transcription Factor 1 (RUNX1) Promotes TGF-β-Induced Renal Tubular Epithelial-to-Mesenchymal Transition (EMT) and Renal Fibrosis through the PI3K Subunit p110δ

EBioMedicine
Tong ZhouHong-Yan Wang

Abstract

Renal fibrosis is widely considered a common mechanism leading to end-stage renal failure. Epithelial-to-mesenchymal transition (EMT) plays important roles in the pathogenesis of renal fibrosis. Runt-related transcription factor 1(RUNX1) plays a vital role in hematopoiesis via Endothelial-to-Hematopoietic Transition (EHT), a process that is conceptually similar to EMT, but its role in EMT and renal fibrosis is unclear. Here, we demonstrate that RUNX1 is overexpressed in the processes of TGF-β-induced partial EMT and renal fibrosis and that the expression level of RUNX1 is SMAD3-dependent. Knockdown of RUNX1 attenuated both TGF-β-induced phenotypic changes and the expression levels of EMT marker genes in renal tubular epithelial cells (RTECs). In addition, overexpression of RUNX1 promoted the expression of EMT marker genes in renal tubular epithelial cells. Moreover, RUNX1 promoted TGF-β-induced partial EMT by increasing transcription of the PI3K subunit p110δ, which mediated Akt activation. Specific deletion of Runx1 in mouse RTECs attenuated renal fibrosis, which was induced by both unilateral ureteral obstruction (UUO) and folic acid (FA) treatment. These findings suggest that RUNX1 is a potential target for preventing renal ...Continue Reading

Citations

Feb 3, 2019·The Journal of Pharmacology and Experimental Therapeutics·Robert B CameronRick G Schnellmann
Jul 10, 2019·Acta Biochimica Et Biophysica Sinica·Xiaolin WangTao Yang
Nov 28, 2019·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Chiara FormicaDorien J M Peters
Feb 14, 2020·PloS One·Katarina ZmajkovicovaJohn Gatfield
Mar 11, 2020·Cardiovascular Research·Alexandra RiddellTamara P Martin
Sep 30, 2019·Cellular and Molecular Life Sciences : CMLS·Loka R Penke, Marc Peters-Golden
Jun 23, 2020·Cell Death Discovery·Antonina ParafioritiAnna Concetta Berardi
Dec 6, 2018·Journal of Cellular Physiology·Deli HongGary S Stein
Jun 30, 2019·Nature Communications·Rodrigo Diéguez-HurtadoRalf H Adams
Jun 9, 2020·Frontiers in Immunology·Amani Abraheem Alsadiq AlyaseerTarcio Teodoro Braga
Dec 18, 2020·JCI Insight·Katie L ConnorLaura Denby
Mar 12, 2020·Cancer Research·Nicholas RooneyKaren Blyth
Feb 13, 2021·Analytical Cellular Pathology (Amsterdam)·Jie SunJia Li
Feb 11, 2021·Cell Death Discovery·Antonina ParafioritiAnna Concetta Berardi
Mar 16, 2021·Environmental Toxicology·Ning LiYulan Jin
Jun 11, 2021·PLoS Genetics·Matthew R HassRaphael Kopan
Sep 1, 2020·Pathology, Research and Practice·Chenghao LuWei Cai
Jul 26, 2021·European Journal of Pharmacology·João FariaRosalinde Masereeuw
Jul 24, 2021·Scientific Reports·Ke GaoZhi-Ming Dai
Nov 6, 2021·Nature Communications·Zhijian LiIvan G Costa
Oct 29, 2021·Bioscience Reports·Pallabi DebnathSantanu Palchaudhuri

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
FACS
Transfection
coimmunoprecipitation
immunoprecipitation

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.